dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Dittner-Moormann, Sabine |
dc.contributor.author | Reschke, Madlen |
dc.contributor.author | Abbink, Floor |
dc.contributor.author | AERTS, isabelle |
dc.contributor.author | Atalay, Hatice Tuba |
dc.contributor.author | Fedorovna Bobrova, Nadezhda |
dc.contributor.author | Sábado Álvarez, Constantino |
dc.date.accessioned | 2022-06-02T08:43:47Z |
dc.date.available | 2022-06-02T08:43:47Z |
dc.date.issued | 2021-06 |
dc.identifier.citation | Dittner‐Moormann S, Reschke M, Abbink FCH, Aerts I, Atalay HT, Fedorovna Bobrova N, et al. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatr Blood Cancer. 2021 Jun;68(6):e28963. |
dc.identifier.issn | 1545-5017 |
dc.identifier.uri | https://hdl.handle.net/11351/7617 |
dc.description | Quimioterapia; Cáncer infantil; Radioterapia |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Pediatric Blood & Cancer;68(6) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Retina - Càncer - Quimioteràpia |
dc.subject | Retina - Càncer - Radioteràpia |
dc.subject | Enquestes |
dc.subject.mesh | Retinoblastoma |
dc.subject.mesh | Combined Modality Therapy |
dc.subject.mesh | Risk Factors |
dc.subject.mesh | Surveys and Questionnaires |
dc.title | Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/pbc.28963 |
dc.subject.decs | retinoblastoma |
dc.subject.decs | tratamiento combinado |
dc.subject.decs | factores de riesgo |
dc.subject.decs | encuestas y cuestionarios |
dc.relation.publishversion | https://doi.org/10.1002/pbc.28963 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Dittner-Moormann S] Department of Pediatric Hematology and Oncology, University Duisburg-Essen, University Hospital Essen, Essen, Germany. [Reschke M] Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany. [Abbink FCH] Amsterdam UMC, Location VU University Medical Centre, Amsterdam, The Netherlands. [Aerts I] Institut Curie, PSL Research University and University of Paris, Paris, France. [Atalay HT] Gazi University School of Medicine, Ankara, Turkey. [Fedorovna Bobrova N] Filatov Eye Institute Odessa, Odessa, Ukraine. [Sábado Álvarez C] Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33720495 |
dc.identifier.wos | 000628887900001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |